In brief
On 20 October 2023, the Cyber Security Agency of Singapore (CSA), in collaboration with the Ministry of Health (MOH), Health Sciences Authority (HSA) and national health technology agency, Synapxe, launched the Cybersecurity Labelling Scheme for Medical Devices (CLS(MD)) sandbox.
Medical device manufacturers are invited to participate in the sandbox to gain a first-mover advantage in enhancing the security of their products.
Background
The CLS(MD) was first announced in October last year during the Singapore International Cyber Week 2022. As reported in our previous alert, the objective of the scheme is to incentivize medical device manufacturers to adopt a security-by-design approach and enable consumers and healthcare providers to make more informed decisions about the use of such devices based on their cybersecurity provisions.
The CLS(MD) covers medical devices that handle personal identifiable information and clinical data, or that are able to connect to other devices, systems and services.
Launch of CLS(MD) Sandbox
Following an industry consultation earlier this year (as reported in our previous alert), the CLS(MD) sandbox was launched on 20 October 2023. It will run for a period of nine months.
During this period, medical device manufacturers will be able to apply to participate in the sandbox and have their medical devices put through different assessments to attain a rating under the CLS(MD).
To recap, there are four levels of rating under the CLD(MD), with Level 4 being the highest rating. Each additional level represents an additional level of testing and assessment for the medical device. The refined requirements to be implemented in the sandbox are as follows:
The sandbox will allow manufacturers to test out and provide feedback on the requirements and application processes for the CLS(MD) ahead of its launch. Feedback and learning from the sandbox will be used to refine the requirements and operational workflow of the scheme where necessary.
*****
For further information and to discuss what this development might mean for you, please get in touch with your usual Baker McKenzie contact. We would be pleased to assist in your application to participate in the CLS(MD) sandbox.
*****
© 2023 Baker & McKenzie.Wong & Leow. All rights reserved. Baker & McKenzie.Wong & Leow is incorporated with limited liability and is a member firm of Baker & McKenzie International, a global law firm with member law firms around the world. In accordance with the common terminology used in professional service organizations, reference to a “principal” means a person who is a partner, or equivalent, in such a law firm. Similarly, reference to an “office” means an office of any such law firm. This may qualify as “Attorney Advertising” requiring notice in some jurisdictions. Prior results do not guarantee a similar outcome.